Prinzide Related Published Studies
Well-designed clinical trials related to Prinzide (Lisinopril / Hydrochlorothiazide)
Effect of telmisartan/hydrochlorothiazide vs lisinopril/hydrochlorothiazide combination on ambulatory blood pressure and cognitive function in elderly hypertensive patients. [2006.03]
Aggressive antihypertensive therapy based on hydrochlorothiazide, candesartan or lisinopril as initial choice in hypertensive type II diabetic individuals: effects on albumin excretion, endothelial function and inflammation in a double-blind, randomized clinical trial. [2005.06]
Clarithromycin suspension: bioequivalence studies on two different strengths. [2004.09]
Comparison of valsartan 160 mg with lisinopril 20 mg, given as monotherapy or in combination with a diuretic, for the treatment of hypertension: the Blood Pressure Reduction and Tolerability of Valsartan in Comparison with Lisinopril (PREVAIL) study. [2004.06]
Comparative bioavailability of two immediate-release tablets of lisinopril/hydrochlorothiazide in healthy volunteers. [2003.07]
Lisinopril-mediated regression of myocardial fibrosis in patients with hypertensive heart disease. [2000.09.19]
Comparison of the AT1-receptor blocker, candesartan cilexetil, and the ACE inhibitor, lisinopril, in fixed combination with low dose hydrochlorothiazide in hypertensive patients. [2000.04]
Lisinopril versus enalapril: evaluation of trough:peak ratio by ambulatory blood pressure monitoring. [1999.06]
Comparison of telmisartan with lisinopril in patients with mild-to-moderate hypertension. [1999.05]
Lisinopril versus hydrochlorothiazide in obese hypertensive patients: a multicenter placebo-controlled trial. Treatment in Obese Patients With Hypertension (TROPHY) Study Group. [1997.07]
[Comparison of antihypertensive and metabolic effects of lisinopril 20 mg/hydrochlorothiazide 12.5 mg fixed combination and captopril 50 mg/hydrochlorothiazide 25 mg fixed combination] [1997.05]
Effects of lisinopril or lisinopril/hydrochlorothiazide compared with adjusting of previous medication and intensifying non-pharmacological treatment in patients with mild to moderate hypertension. [1997.02]
Valsartan, a new angiotensin II receptor antagonist: a double-blind study comparing the incidence of cough with lisinopril and hydrochlorothiazide. [1997.02]
[Comparison of metabolic and hemodynamic effects of hydrochlorothiazide in monotherapy and in association with lisinopril. An Italian multicenter study] [1995.09]
Comparison of the hemodynamic and metabolic effects of low-dose hydrochlorothiazide and lisinopril treatment in obese patients with high blood pressure. [1995.05]
Comparison of the efficacy and tolerability of an angiotensin converting enzyme inhibitor (lisinopril) versus a calcium channel antagonist (diltiazem SR) in the treatment of moderate to severe hypertension. [1994.07]
Antihypertensive effectiveness of low-dose lisinopril-hydrochlorothiazide combination. A large multicenter study. Lisinopril-Hydrochlorothiazide Group. [1994.04.11]
[Evaluation of lisinopril and lisinopril-hydrochlorothiazide combination in mild to moderate arterial hypertension] [1994.01]
A comparison of lisinopril and nifedipine in the treatment of mild to moderate hypertension. A multicentre study. [1994]
[Evaluation of the antihypertensive efficacy of lisinopril and captopril associated with hydrochlorothiazide by ambulatory measurement of arterial pressure] [1993.12]
Effects of lisinopril and hydrochlorothiazide on platelet function and blood rheology in essential hypertension: a randomly allocated double-blind study. [1993.05]
Effects of hydrochlorothiazide, amiloride, and lisinopril on the metabolic response to adrenaline infusions in normal subjects. [1992.06]
Comparison of the effects of isradipine and lisinopril on left ventricular structure and function in essential hypertension. [1992.05.01]
A comparison of the effect of lisinopril and hydrochlorothiazide on electrolyte balance in essential hypertension. [1992]
Lisinopril-hydrochlorothiazide combination compared with the monocomponents in elderly hypertensive patients. [1991.12]
The pharmacokinetics of co-administered lisinopril and hydrochlorothiazide. [1991.12]
Controlling hypertension: lisinopril-hydrochlorothiazide vs captopril-hydrochlorothiazide. An Italian multicentre study. [1991.12]
Lisinopril-hydrochlorothiazide combination vs lisinopril for the treatment of hypertension. [1991.12]
Introduction to lisinopril-hydrochlorothiazide combination. [1991.12]
Comparison of long-term hemodynamic effects at rest and during exercise of lisinopril plus sodium restriction versus hydrochlorothiazide in essential hypertension. [1990.02.01]
ACE inhibitors in mild to moderate hypertension: comparison of lisinopril and captopril administered once daily. French Cooperative Study Group. [1989.06]
Lisinopril in essential hypertension: a six month comparative study with nifedipine. [1987.12]
Well-designed clinical trials possibly related to Prinzide (Lisinopril / Hydrochlorothiazide)
Gender difference in the response to an angiotensin-converting enzyme inhibitor and a diuretic in hypertensive patients of African descent. [2004.06]
Cardiovascular events in elderly patients with isolated systolic hypertension. A subgroup analysis of treatment strategies in STOP-Hypertension-2. [2004]
Effects of non-steroidal anti-inflammatory drugs on hypertension control using angiotensin converting enzyme inhibitors and thiazide diuretics. [2001.10]
[Calcium antagonists in cardiovascular disease. Clinical evidence from morbidity and mortality trials] [2000]
Randomised trial of old and new antihypertensive drugs in elderly patients: cardiovascular mortality and morbidity the Swedish Trial in Old Patients with Hypertension-2 study. [1999.11.20]
Nocturnal reduction of blood pressure and the antihypertensive response to a diuretic or angiotensin converting enzyme inhibitor in obese hypertensive patients. TROPHY Study Group. [1998.08]
Comparison of different fixed antihypertensive combination drugs: a double-blind, placebo-controlled parallel group study. [1997.01]
ACE inhibitors, angiotensin II antagonists and cough. The Losartan Cough Study Group. [1995.11]
Modulation of the renin-angiotensin-aldosterone system and cough. [1995.08]
Effects of different antihypertensive drugs on plasma fibrinogen in hypertensive patients. [1995.05]
Effects of modulators of the renin-angiotensin-aldosterone system on cough. Losartan Cough Study Group. [1994.12]
Association between cough and angiotensin converting enzyme inhibitors versus angiotensin II antagonists: the design of a prospective, controlled study. [1994.07]
Response of ambulatory blood pressure to antihypertensive therapy guided by clinic pressure. [1993.08]
APTH--a trial on ambulatory blood pressure monitoring and treatment of hypertension: objectives and protocol. [1993]
Glucose and lipid metabolism in essential hypertension: effects of diuretics and ACE-inhibitors. [1993]
Which anti-hypertensive to add to a beta-blocker: ACE inhibitor or diuretic? [1992.04]
Treatment of arterial hypertension in diabetic humans: importance of therapeutic selection. [1992.04]
Diltiazem: its place in the antihypertensive armamentarium. [1991]
ACE inhibition and pressor responsiveness to norepinephrine in hypertensive patients. [1990.05]
Other research related to Prinzide (Lisinopril / Hydrochlorothiazide)
Hydrochlorothiazide increases plasma or tissue angiotensin-converting enzyme-inhibitor drug levels in rats with myocardial infarction: differential effects on lisinopril and zofenopril. [2005.12.19]
Effect of telmisartan/hydrochlorothiazide vs lisinopril/hydrochlorothiazide combination on ambulatory blood pressure and cognitive function in elderly hypertensive patients. [2005.11.24]
Reproducibility and clinical value of nocturnal hypotension: prospective evidence from the SAMPLE study. Study on Ambulatory Monitoring of Pressure and Lisinopril Evaluation. [1998.06]
Long-term evaluation of combined antihypertensive therapy with lisinopril and a thiazide diuretic in patients with essential hypertension. [1997.11]
Antihypertensive effects of combined lisinopril and hydrochlorothiazide in elderly patients with systodiastolic or systolic hypertension: results of a multicenter trial. [1997.11]
Ambulatory blood pressure is superior to clinic blood pressure in predicting treatment-induced regression of left ventricular hypertrophy. SAMPLE Study Group. Study on Ambulatory Monitoring of Blood Pressure and Lisinopril Evaluation. [1997.03.18]
[A multicenter study of lisinopril in the treatment of mild to moderate hypertension] [1995.07]
[The antihypertensive effects of the lisinopril-hydrochlorothiazide combination (Zestoretic) in elderly hypertensive patients. The results of a multicenter study. The Italian Zestoretic Study Group] [1994.10]
The effects of age and renal impairment on the pharmacokinetics of co-administered lisinopril and hydrochlorothiazide. [1991.12]
Review of international safety data for lisinopril-hydrochlorothiazide combination treatment. [1991.12]
Lisinopril versus slow-release nifedipine in the treatment of mild to moderate hypertension: a multicentre study. The Cooperative Study Group. [1989.06]
Clinical experience with lisinopril. Observations on safety and tolerability. [1989.06]
Lisinopril in the treatment of hypertension. [1989.06]
The antihypertensive response to lisinopril: the effect of age in a predominantly black population. [1989.01]
Safety and tolerability of lisinopril in older hypertensive patients. [1988.09.23]
Clinical experience and rationale for angiotensin-converting enzyme inhibition with lisinopril as the initial treatment for hypertension in older patients. [1988.09.23]
Plasma lipid profiles and antihypertensive agents: effects of lisinopril, enalapril, nitrendipine, hydralazine, and hydrochlorothiazide. [1988.07]
Lisinopril. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension and congestive heart failure. [1988.06]
Lisinopril versus lisinopril plus hydrochlorothiazide in essential hypertension. [1988.04.01]
A 52-week comparison of lisinopril, hydrochlorothiazide, and their combination in hypertension. [1987.05]
Other possibly related research studies
Posting guidelines: a practical and effective way to promote appropriate hypertension treatment. [2005.04]
High prevalence of orthostatic hypotension and its correlation with potentially causative medications among elderly veterans. [2005.04]
The effect of combination therapy on regression of left ventricular hypertrophy in cases with hypertension. [2004.12]
Antihypertensive therapy increases cerebral blood flow and carotid distensibility in hypertensive elderly subjects. [2005.02]
Relationship between acute pancreatitis and ACE inhibitors. [2004.10]
Cardiovascular drugs and serum uric acid. [2003.09]
Trandolapril: a newer angiotensin-converting enzyme inhibitor. [2003.03]
[Effectiveness of combined therapy at set doses in a cohort of hypertense patients not controlled by single therapy] [2003.02.28]
[Drug-induced acute pancreatitis: a personal contribution] [2002.09]
Gateways to Clinical Trials. [2002.09]
Fixed combination trandolapril/verapamil sustained-release: a review of its use in essential hypertension. [2002]
Combination therapy with AT(1)-receptor blockers. [2002.08]
Candesartan cilexetil plus hydrochlorothiazide combination: a review of its use in hypertension. [2002]
Telmisartan: a review of its use in hypertension. [2001]
Antihypertensive drug prescription trends at the primary health care centres in Bahrain. [2001.05]
A pharmacodynamic assessment of the impact of antihypertensive non-adherence on blood pressure control. [2000.12]
Midwall mechanics are improved after regression of hypertensive left ventricular hypertrophy and normalization of chamber geometry. [2001.02.06]
The incidence of active duty dental patients taking antihypertensive medications. [1999.10]
Nebivolol in the management of essential hypertension: a review. [1999.04]
The smoothness index: a new, reproducible and clinically relevant measure of the homogeneity of the blood pressure reduction with treatment for hypertension. [1998.11]
Fixed combination verapamil SR/trandolapril. [1998.11]
Reproducibility and clinical value of the trough-to-peak ratio of the antihypertensive effect: evidence from the sample study. [1998.09]
The blunting of the antiproteinuric efficacy of ACE inhibition by high sodium intake can be restored by hydrochlorothiazide. [1998.07]
Valsartan. A review of its pharmacology and therapeutic use in essential hypertension. [1997.08]
Losartan: first of a new class of angiotensin antagonists for the management of hypertension. [1996.01]
[Life-threatening postoperative angioedema following treatment with an angiotensin converting enzyme inhibitor] [1995.12]
Salivary function and hypertension: a review of the literature and a case report. [1995.07]
Trandolapril. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in essential hypertension. [1994.07]
Effects of angiotensin-converting enzyme inhibitors on glucose and lipid metabolism in essential hypertension. [1994.01]
Interaction between antihypertensives and NSAIDs in primary care: a controlled trial. [2008.09]
|
